Use of a melanoma inhibiting activity factor (MIA) for cartilage and bone repair

US6890897B1 · kind B1 · utility

Assignee

• SCIL TECHNOLOGY GMBH · DE

Inventors

• Carola Dony · Starnberg, DE
• Gabriele Proetzel · Schwanfeld, DE
• Ulrike Leser-Reiff · Penzberg, DE

Key dates

• Filing date: Jan 27, 2000
• Grant date: May 10, 2005
• Expiry date: Jan 27, 2020

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61K38/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

A melanoma inhibiting activity factor (MIA), preferably in combination with an osteoinductive protein, is a useful pharmaceutical agent for promoting bone healing and/or cartilage repair.